Top

Published in:

01-11-2020 | Hemophagocytic Lymphohistiocytosis | Letter to Editor

Disseminated Mycobacterium xenopi in an Adult with IL-12Rβ1 Deficiency

Authors: Boaz Palterer, Filippo Bartalesi, Alessio Mazzoni, Laura Maggi, Aldesia Provenzano, Federica Vergoni, Sabrina Giglio, Francesco Annunziato, Paola Parronchi

Published in: Journal of Clinical Immunology | Issue 8/2020

Excerpt

To the Editor, …

Available only for authorised users

de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 2010;89:381–402. https://doi.org/10.1097/MD.0b013e3181fdd832.CrossRef

Ouederni M, Sanal O, Ikincioğullari A, Tezcan I, Dogu F, Sologuren I, et al. Clinical features of candidiasis in patients with inherited interleukin 12 receptor β1 deficiency. Clin Infect Dis. 2014;58:204–13. https://doi.org/10.1093/cid/cit722.CrossRefPubMed

Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency. J Exp Med. 2003;197:527–35. https://doi.org/10.1084/jem.20021769.CrossRefPubMedPubMedCentral

Mencarini J, Cresci C, Simonetti MT, Truppa C, Camiciottoli G, Frilli ML, et al. Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease. Epidemiol Infect. 2017;145:515–22. https://doi.org/10.1017/S0950268816002521.

Picard C, Bobby Gaspar H, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38:96–128. https://doi.org/10.1007/s10875-017-0464-9.

Sanal O, Turul T, De Boer T, Vosse EVD, Yalcin I, Tezcan I, et al. Presentation of interleukin-12/−23 receptor β1 deficiency with various clinical symptoms of Salmonella infections. J Clin Immunol. 2006;26:1–6. https://doi.org/10.1007/s10875-006-7830-3.

Chapgier A, Kong X-F, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest. 2009;119:1502–14. https://doi.org/10.1172/JCI37083.CrossRefPubMedPubMedCentral

Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, et al. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine–derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020;8:1371–86. https://doi.org/10.1016/j.jaip.2020.01.038.CrossRefPubMed

Bustamante J, Boisson-Dupuis S, Abel L, Casanova J-L. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26:454–70. https://doi.org/10.1016/j.smim.2014.09.008.CrossRefPubMedPubMedCentral

10.

Schwabacher H. A strain of mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis , and its relation to atypical acid-fast bacilli occurring in man. J Hyg (Lond). 1959;57:57–67. https://doi.org/10.1017/S0022172400019896.CrossRef

11.

Staines-Boone AT, Deswarte C, Venegas Montoya E, Sánchez-Sánchez LM, García Campos JA, Muñiz-Ronquillo T, et al. Multifocal recurrent osteomyelitis and hemophagocytic lymphohistiocytosis in a boy with partial dominant IFN-γR1 deficiency: case report and review of the literature. Front Pediatr. 2017;5:75. https://doi.org/10.3389/fped.2017.00075.CrossRefPubMedPubMedCentral

Title: Disseminated Mycobacterium xenopi in an Adult with IL-12Rβ1 Deficiency
Authors: Boaz Palterer
Filippo Bartalesi
Alessio Mazzoni
Laura Maggi
Aldesia Provenzano
Federica Vergoni
Sabrina Giglio
Francesco Annunziato
Paola Parronchi
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Hemophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis
Published in: Journal of Clinical Immunology / Issue 8/2020
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-020-00848-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2020

Phenoidentical HLA-Related Hematopoietic Stem Cell Transplant Without Conditioning to Reconstitute a Patient with a Putative Loss-of-Function CARD11 Mutation

Nocardiosis Associated with Primary Immunodeficiencies (Nocar-DIP): an International Retrospective Study and Literature Review

Case Report: Acute Thrombotic Microangiopathy in a Patient with STING-Associated Vasculopathy with Onset in Infancy (SAVI)

Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome

Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy

X-Linked Thrombocytopenia and Vanishing White Matter Disease in a Child: Double Tragedy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials